Lamotrigine reduces total postoperative analgesic requirement: a randomized double-blind, placebo-controlled pilot study

Surgery. 1997 Sep;122(3):567-70. doi: 10.1016/s0039-6060(97)90129-x.

Abstract

Background: Postoperative pain is undertreated. Lamotrigine, a new antiepileptic drug, has analgesic properties in its antisodium and antiglutamatergic effects. It may prevent postoperative pain. This pilot study assessed lamotrigine effects on postoperative pain.

Methods: This was a double-blind, randomized, placebo-controlled pilot study of 30 patients submitted to transurethral prostatectomy under spinal anesthesia and receiving 200 mg of lamotrigine 1 hour before spinal anesthesia.

Results: We observed a statistically significant reduction in total analgesic assumption (p < 0.01) and in visual analog scale scores at 2 (p = 0.04), 4 (p < 0.01), and 6 (p = 0.04) hours after operation.

Conclusions: Lamotrigine may be an effective means of reducing postoperative pain.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adenoma / surgery
  • Aged
  • Analgesics / therapeutic use*
  • Anesthesia, Spinal
  • Double-Blind Method
  • Humans
  • Lamotrigine
  • Male
  • Middle Aged
  • Pain, Postoperative / drug therapy*
  • Pilot Projects
  • Placebos
  • Postoperative Care*
  • Preoperative Care*
  • Prostatectomy*
  • Prostatic Neoplasms / surgery
  • Triazines / therapeutic use*

Substances

  • Analgesics
  • Placebos
  • Triazines
  • Lamotrigine